🇺🇸 FDA
Patent

US 8304557

Fused heterocycle derivatives and use thereof

granted A61PA61P11/06A61P13/12

Quick answer

US patent 8304557 (Fused heterocycle derivatives and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P11/06, A61P13/12, A61P15/00, A61P17/06